Brentuximab vedotin for relapsed or refractory CD30+...

  • Main
  • 2014 / 09
  • Brentuximab vedotin for relapsed or refractory CD30+...
OncoTargets and Therapy 2014 / 09

Brentuximab vedotin for relapsed or refractory CD30+ Hodgkin lymphoma: a multicenter analysis from Asia

Hong, Jung Yong, Ko, Young Hyeh, Lin, Shek-Ying, Au, Wing-Yan, Kim, Seok Jin, Kim, Won Seog, Choi, Moon Ki, Qing-Ming Yang, Qing-Ming, Park, Silvia
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
OncoTargets and Therapy
DOI:
10.2147/OTT.S67380
Date:
September, 2014
File:
PDF, 613 KB
english, 2014
Conversion to is in progress
Conversion to is failed